Geraghty James A Insider Trades

Insider Trading History

Track insider trading activity for Geraghty James A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $121k 36,000 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266k 36,000 shares
$7.38
$3.37
Voyager Therapeutics
Voyager Therapeutics VYGR
Director
Holding Value $86.9k 24,000 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.7k 24,000 shares
$3.28
$3.62
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.1 1 shares
$16.13
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $13.6 1 shares
Last Trade
Aug 07, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.5 1 shares
$16.46
$13.60
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $101k 30,000 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 30,000 shares
$7.00
$3.37
Voyager Therapeutics
Voyager Therapeutics VYGR
Director
Holding Value $86.9k 24,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 24,000 shares
$8.70
$3.62
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $0 0 shares
Last Trade
Jan 24, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.26M 195,391 shares
$16.70
$16.70
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $101k 30,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$94.8k 30,000 shares
$3.16
$3.37
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $612k 45,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.7k 45,000 shares
$0.26
$13.60
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $1.75M 105,000 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$520k 105,000 shares
$4.95
$16.70
Voyager Therapeutics
Voyager Therapeutics VYGR
Director
Holding Value $79.6k 22,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 22,000 shares
$12.57
$3.62
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $64k 19,000 shares
Last Trade
Jun 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.2k 19,000 shares
$5.22
$3.37
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director
Holding Value $11.1k 26,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12k 26,000 shares
$0.46
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director
Holding Value $11.1k 26,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 26,000 shares
$0.46
$0.42
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $612k 45,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.55M 45,000 shares
$145.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $612k 45,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.55M 45,000 shares
$145.60
$13.60
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
Director
Holding Value $768k 46,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 46,000 shares
$4.75
$16.70
Voyager Therapeutics
Voyager Therapeutics VYGR
Director
Holding Value $79.6k 22,000 shares
Last Trade
Jun 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 22,000 shares
$5.27
$3.62
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $306k 90,714 shares
Last Trade
Jun 28, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$91.6k 10,000 shares
$9.16
$3.37
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $612k 45,000 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.4M 45,000 shares
$320.00
$13.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up